In BNCT, 18F-BPA-PET evaluates boron drug distribution for treatment eligibility, but is rarely incorporated into treatment planning. A key limitation is differences in drug administration protocols between PET and BNCT, which may weaken clinical outcome-to-d...
Mitsuko Masutani, PhD
Therapy Physics